my thoughts exactly. the question is, can this management execute? recent higher of ma suggests they are at least humble enough to bring someone in to ramp up manufacturing. good for them.
i have been on the good and bad side of stock 'frenzies' and cygx has the potential to produce one. the next few months will help to clarify the profit potential as they 'hopefully' get and fill at least one, maybe two, gram quantity orders. THIS is what they were most excited about at the SHM and have been illuding to in recent pr for 'follow up' order and in thier words, "multi gram order" on the horizon for the majic stuff.
its the comments from outside sources about synDNA (aldevron and the co that has ordered the two test batches) that impress me and tell me that cygx is doing a much better job at executing the business plan.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.